Results 121 to 130 of about 19,125 (215)

Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis. [PDF]

RMD Open
Finckh A, Courvoisier DS, Aymon R, Mongin D, Saevarsdottir S, Jonsdottir I, Stefansson K, Hetland ML, Moeller B, Villard J, Lauper K, Danish Rheumatologic Biobank Study Group, SCQM Biobank Study Group, Glintborg B, SCQM Biobank study group.   +14 more
europepmc   +1 more source

Comparative Safety Analysis of Targeted Synthetic and Biologic Disease‐Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis: A Nationwide Cohort Study in Japan

International Journal of Rheumatic Diseases, Volume 29, Issue 9, September 2026.
ABSTRACT Aim To compare risks of malignancy, opportunistic infections, and venous thromboembolism between the targeted synthetic disease‐modifying antirheumatic drugs (tsDMARDs) and biologic DMARDs (bDMARDs) at the 2nd and 3rd lines of therapy (LOT). Methods We conducted a cohort study using the National Database of Health Insurance Claims (2013–2021).
Shiori Nishimura, Toshitaka Hirano, Soko Setoguchi, Hiroki Matsui, Yoshinori Takeuchi, Yasushi Inoue, Yoshiya Tanaka, Kunihiro Yamaoka, Yoichi Ii, Shintaro Hiro, Masato Hoshi, Naonobu Sugiyama, Yutaka Matsuyama, Hiraku Kumamaru   +13 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Mental Health Disorders in Type 2 Diabetes: Active Comparator, New User Cohort Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8482-8493, September 2026.
ABSTRACT Aims We evaluated the risk of mental health disorders among glucagon‐like peptide‐1 receptor agonist (GLP1RA) users compared with users of dipeptidyl peptidase‐4 (DPP‐4) inhibitors and sodium‐glucose cotransporter‐2 (SGLT2) inhibitors. Materials and Methods We conducted a nationwide, active‐comparator new‐user cohort study using the Korean ...
Chungsoo Kim, Seonji Kim, Dong Yun Lee, Eugene Han, Yong‐ho Lee, Seng Chan You   +5 more
wiley   +1 more source

Outcomes of Root Canal Treatment in Patients With Autoimmune Disease: A Retrospective Case–Control Study

International Endodontic Journal, Volume 59, Issue 9, Page 1831-1840, September 2026.
ABSTRACT Aim The purpose of this study was to compare the outcome of nonsurgical root canal treatment (RCT) in patients with autoimmune diseases (AD) with the outcome in patients without AD. The null hypothesis was: there is no difference in the outcomes of RCT regardless of the patient group. Results were also compared among AD subgroups: inflammatory
Seoyeon Lee, Euiseong Kim, Hoiin Jung, Hyejin Kim, Sunil Kim   +4 more
wiley   +1 more source

Impact of renal function on the safety of biologic and synthetic DMARDs in rheumatoid arthritis: A retrospective cohort study from a Turkish tertiary center. [PDF]

Medicine (Baltimore)
Bulut Gökten D, Soğur ÖA, Sukhbaatar Z, Mercan R.   +3 more
europepmc   +1 more source

Perioperative Management of Antirheumatic Medications in Adults with Rheumatoid Arthritis Undergoing Arthroplasty and Other Orthopedic Procedures: A Systematic Review. [PDF]

Medicina (Kaunas)
Al-Obaidi I, Alabid I, Al-Dhaheri A, Qassim ZAM, Patni MM, El-Tanani M, Rabbani SA, Shuaeeb A, Aloti RA, Alghoul WII.   +9 more
europepmc   +1 more source

Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop). [PDF]

RMD Open
Dejaco C, Gessl I, Husic R, Mitter G, Deimel T, Lackner A, Supp G, Hermann J, Smolen J, Stradner MH, Aletaha D, Schwantzer G, Mandl P.   +12 more
europepmc   +1 more source

Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention

The Turkish Journal of Gastroenterology
Background/Aims: This study compared the effectiveness, adverse effects (AEs), and drug retention rates of baricitinib (BARI) monotherapy versus combination therapy in rheumatoid arthritis (RA) patients.
Mete Kara, Gülay Alp, Haluk Cinakli
doaj  

Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and Safety. [PDF]

Drug Des Devel Ther
Costa L, Caso F, Maione F, Giacomelli R, Ruscitti P.   +4 more
europepmc   +1 more source

Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real-World Effectiveness and Safety From a Prospective Cohort. [PDF]

ACR Open Rheumatol
Lucas Ribeiro A, Al-Zahir Z, Carrizo Abarza V, Maliyar K, Sood S, Bagit A, Sachdeva M, Koppikar S, Gladman DD, Yeung J, Chandran V, Eder L.   +11 more
europepmc   +1 more source